Manganese produce a parkinsonism-like illness characterized by movement abnormalities. This condition is not responsive to typical therapies used in the treatment of PD, suggesting an alternative pathway than the typical dopaminergic loss within the substantia nigra. Manganese may accumulate in the basal ganglia, leading to the abnormal movements. A mutation of the SLC30A10 gene, a manganese efflux transporter necessary for decreasing intracellular Mn, has been linked with the development of this Parkinsonism-like disease. The Lewy bodies typical to PD are not seen in Mn-induced parkinsonism. Animal experiments have given the opportunity to examine the consequences of manganese overexposure under controlled conditions.
Manganese(II) phosphate due to their toughness. Manganese phosphate coating can often be found in the oil and gas industry, firearms and ordnance, aerospace, gears and bearings, and in marine equipment. They are also common in engines, screws, nuts and bolts, and washers. Manganese(II) phosphate Manganese(II) phosphate is an inorganic compound with the chemical formula Mn(PO). It is a rarely studied species, in contrast to the related lithium manganese phosphate, which has been investigated as a battery cathode. Manganese phosphates often combine with iron phosphates through paragenesis. In the process of paragenesis, each mineral affects the manner in which the other is crystallized.